Skip to content

Why Healthcare Stocks Are Volatile Ahead Of Congress

November 8, 2026 · 11 min

Show notes

With the new Congress taking shape and healthcare stocks like Pfizer and Moderna swinging wildly, investors are asking if the sector is finally priced for change. Lucas and Luna break down how political uncertainty is creating a unique opportunity in biotech and pharma. They analyze why the market is punishing established giants while rewarding innovation-focused players, and what the latest Fed rate data means for capital-intensive R&D cycles. If you hold healthcare ETFs or individual names, this episode explains the structural shifts you need to watch before the next earnings season.

#HealthcareInvesting #BiotechStocks #Congress2026 #PfizerAnalysis #ModernaNews #FedInterestRates #PharmaMargins #PortfolioRisk #MarketVolatility #LongTermWealth #FexingoBusiness #BusinessPodcast #FinanceNews #InvestmentStrategy #EconomicIndicators #InflationData #StockMarketTrends #CorporateEarnings

Keep every episode free: buymeacoffee.com/fexingo

All episodes of The Investing Podcast with Fexingo: Stocks, Bonds, and Building a Long-Term Portfolio

Settings

Display

Language

Decides which stations you see first on the home page.

History

Recently played stations and episodes and your latest searches are only stored in this browser.

Notifications

A short notice when a podcast you follow has a new episode. Turn off single podcasts with the bell on their page.

Account

Save favorites – in the app and on the website.

Keyboard shortcuts

/
Open search
Space
Play or pause
← →
In the player: back 15 s, forward 30 s (episodes) · in a row: next tile
↑ ↓
In a row: target within the tile
Home / End
In a row: first or last tile
Esc
Close window or menu
?
This overview
Now playing

Go to station page

Play next

    Add episodes with “Play next” – they play after the current episode.